Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
The Journal of Prevention of Alzheimer'S Disease
|
January 12, 2025
Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation
Jeffrey Cummings, Michael Gold, Mark Mintun, et al.
Pediatrics
|
June 1, 2016
A Quality Assessment of a Collaborative Model of a Pediatric Antimicrobial Stewardship Program
Phuong-Tan Nguyen-Ha, Denise Howrie, Kelli Crowley, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 28, 2004
Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy
Thomas A Buchholz, Eugene H Huang, Donald Berry, et al.
Arxiv
|
August 6, 2025
Decoding Neural Signatures of Semantic Evaluation in Depression and Suicidality
Woojae Jeong, Aditya Kommineni, Kleanthis Avramidis, et al.
Communications Biology
|
April 30, 2026
Time-resolved EEG decoding reveals altered neural dynamics of affective semantic evaluation in depression and suicidality
Woojae Jeong, Aditya Kommineni, Kleanthis Avramidis, et al.
The New England Journal of Medicine
|
September 3, 2004
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer
Kevin S Hughes, Lauren A Schnaper, Donald Berry, et al.
International Journal of Cancer
|
May 12, 2020
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma
Elizabeth C Lewis, Jacqueline M Kraveka, William Ferguson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2020
Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer
Aranzazu Fernandez-Martinez, Ian E Krop, David W Hillman, et al.
JCO Precision Oncology
|
September 11, 2020
Evaluation of the HER/PI3K/AKT Family Signaling Network as a Predictive Biomarker of Pathologic Complete Response for Patients With Breast Cancer Treated With Neratinib in the I-SPY 2 TRIAL
Julia D Wulfkuhle, Christina Yau, Denise M Wolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study
Simrit Parmar, Borje S Andersson, Daniel Couriel, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
The Journal of Prevention of Alzheimer'S Disease
|
January 12, 2025
Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation
Jeffrey Cummings, Michael Gold, Mark Mintun, et al.
Pediatrics
|
June 1, 2016
A Quality Assessment of a Collaborative Model of a Pediatric Antimicrobial Stewardship Program
Phuong-Tan Nguyen-Ha, Denise Howrie, Kelli Crowley, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 28, 2004
Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy
Thomas A Buchholz, Eugene H Huang, Donald Berry, et al.
Arxiv
|
August 6, 2025
Decoding Neural Signatures of Semantic Evaluation in Depression and Suicidality
Woojae Jeong, Aditya Kommineni, Kleanthis Avramidis, et al.
Communications Biology
|
April 30, 2026
Time-resolved EEG decoding reveals altered neural dynamics of affective semantic evaluation in depression and suicidality
Woojae Jeong, Aditya Kommineni, Kleanthis Avramidis, et al.
The New England Journal of Medicine
|
September 3, 2004
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer
Kevin S Hughes, Lauren A Schnaper, Donald Berry, et al.
International Journal of Cancer
|
May 12, 2020
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma
Elizabeth C Lewis, Jacqueline M Kraveka, William Ferguson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2020
Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer
Aranzazu Fernandez-Martinez, Ian E Krop, David W Hillman, et al.
JCO Precision Oncology
|
September 11, 2020
Evaluation of the HER/PI3K/AKT Family Signaling Network as a Predictive Biomarker of Pathologic Complete Response for Patients With Breast Cancer Treated With Neratinib in the I-SPY 2 TRIAL
Julia D Wulfkuhle, Christina Yau, Denise M Wolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study
Simrit Parmar, Borje S Andersson, Daniel Couriel, et al.
Page
of 6